News

December 11, 2017

Cytokinetics Publishes Clinical Trial Data for CK-2127107

Cytokinetics Publishes Clinical Trial Data for CK-2127107

Cytokinetics, Inc. recently announced the publication of results from three early clinical trials in healthy volunteers that evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of CK-2127107. The data supports the ongoing Phase 2 trial of the drug in patients with spinal...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

November 27, 2017

Cure SMA-Funded Researcher, Stephen Kolb, Publishes Paper

Cure SMA-Funded Researcher, Stephen Kolb, Publishes Paper

Cure SMA-funded researcher Stephen Kolb has published a paper in the journal Annals of Neurology, on the results of a study comparing infants affected by SMA with healthy infants of the same age. This paper reported on...

READ MORE   |  

Topics: Our Impact, Research, Front Page News

November 7, 2017

Biogen Issues Community Update on Spinraza

Biogen Issues Community Update on Spinraza

Biogen has provided the following community statement on Spinraza. 

Dear Members of the SMA community,

As part of our commitment to the SMA community to provide ongoing and comprehensive communications about SPINRAZA® (nusinersen), we are pleased to share that the...

READ MORE   |  

Topics: Clinical Trials, Research, Front Page News

Items 1 - 3 of 166  12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software